Evidence map›Paper›PMID 19933160›Full record

ArticleBioinformatics (Oxford, England)2010

MADS+: discovery of differential splicing events from Affymetrix exon junction array data.

Shihao Shen, Claude C Warzecha, Russ P Carstens, Yi Xing

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Alternative Splicing Regulation in Metabolic Disorders.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. eQTL Mapping Using RNA-seq Data.Statistics in biosciences · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shihao ShenDepartment of Biostatistics, University of Iowa, Iowa City, IA, USA.
Claude C Warzecha
Russ P Carstens
Yi Xing
University of Iowa · US

Funding

UNIVERSITY OF IOWA CTSA FOR PEDIATRIC RESEARCHUL1RR024979 · NCRR · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2007 to 2011
$31.8M
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMTR01GM088809 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI CARSTENS, RUSS PAUL · 2009 to 2013
$1.5M
Statistical Analysis of Exon ArraysR01HG004634 · NHGRI · STANFORD UNIVERSITY · PI WONG, WING H. · 2008 to 2011
$1.4M
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCERR01CA093769 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CARSTENS, RUSS PAUL · 2003 to 2007
$1.3M
NCI NIH HHS R01 CA093769NCI NIH HHS R01-CA093769NCRR NIH HHS UL1 RR024979NHGRI NIH HHS R01 HG004634NHGRI NIH HHS R01-HG004634NIGMS NIH HHS R01 GM088809
6 · The paper itself

Abstract

motivationThe Affymetrix Human Exon Junction Array is a newly designed high-density exon-sensitive microarray for global analysis of alternative splicing. Contrary to the Affymetrix exon 1.0 array, which only contains four probes per exon and no probes for exon-exon junctions, this new junction array averages eight probes per probeset targeting all exons and exon-exon junctions observed in the human mRNA/EST transcripts, representing a significant increase in the probe density for alternative splicing events. Here, we present MADS+, a computational pipeline to detect differential splicing events from the Affymetrix exon junction array data. For each alternative splicing event, MADS+ evaluates the signals of probes targeting competing transcript isoforms to identify exons or splice sites with different levels of transcript inclusion between two sample groups. MADS+ is used routinely in our analysis of Affymetrix exon junction arrays and has a high accuracy in detecting differential splicing events. For example, in a study of the novel epithelial-specific splicing regulator ESRP1, MADS+ detects hundreds of exons whose inclusion levels are dependent on ESRP1, with a RT-PCR validation rate of 88.5% (153 validated out of 173 tested). AVAILABILITY: MADS+ scripts, documentations and annotation files are available at http://www.medicine.uiowa.edu/Labs/Xing/MADSplus/.

Indexed as

ExonsSoftwareAlternative SplicingHumansOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionSequence Analysis, RNA

Identifiers

PMID19933160
PMCPMC2804303
OpenAlexW2146457918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.